|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer
in: 2008 GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Curado MP: Breast cancer in the world:
Incidence and mortality. Salud Publica Mex. 53:372–384.
2011.PubMed/NCBI
|
|
3
|
Li CI, Anderson BO, Daling JR and Moe RE:
Trends in incidence rates of invasive lobular and ductal breast
carcinoma. JAMA. 289:1421–1424. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ernster VL, Barclay J, Kerlikowske K,
Grady D and Henderson C: Incidence of and treatment for ductal
carcinoma in situ of the breast. JAMA. 275:913–918. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee S, Stewart S, Nagtegaal I, Luo J, Wu
Y, Colditz G, Medina D and Allred DC: Differentially expressed
genes regulating the progression of ductal carcinoma in situ to
invasive breast cancer. Cancer Res. 72:4574–4586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wojnar A, Pula B, Piotrowska A, Jethon A,
Kujawa K, Kobierzycki C, Rys J, Podhorska-Okolow M and Dziegiel P:
Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2
proteins in invasive ductal breast carcinoma. Anticancer Res.
31:3027–3033. 2011.PubMed/NCBI
|
|
7
|
Nanashima A, Hatachi G, Tsuchiya T,
Matsumoto H, Arai J, Abo T, Murakami G, Tominaga T, Takagi K and
Nagayasu T: Clinical significances of cancer stem cells markers in
patients with intrahepatic cholangiocarcinoma who underwent
hepatectomy. Anticancer Res. 33:2107–2114. 2013.PubMed/NCBI
|
|
8
|
Madjd Z, Ramezani B, Molanae S and
Asadi-Lari M: High expression of stem cell marker ALDH1 is
associated with reduced BRCA1 in invasive breast carcinomas. Asian
Pac J Cancer Prev. 13:2973–2978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gil J, Stembalska A, Pesz KA and Sasiadek
MM: Cancer stem cells: The theory and perspectives in cancer
therapy. J Appl Genet. 49:193–199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang R, Chadalavada K, Wilshire J, Kowalik
U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C and
Tabar V: Glioblastoma stem-like cells give rise to tumour
endothelium. Nature. 468:829–833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau
CK, Li ML, Tam KH, Lam CT, Poon RT and Fan ST: Identification of
local and circulating cancer stem cells in human liver cancer.
Hepatology. 47:919–928. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wright MH, Calcagno AM, Salcido CD,
Carlson MD, Ambudkar SV and Varticovski L: Brca1 breast tumors
contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell
characteristics. Breast Cancer Res. 10:R102008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu Y and Wu PY: CD133 as a marker for
cancer stem cells: Progresses and concerns. Stem Cells Dev.
18:1127–1134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frierson HF Jr, Wolber RA, Berean KW,
Franquemont DW, Gaffey MJ, Boyd JC and Wilbur DC: Interobserver
reproducibility of the Nottingham modification of the Bloom and
Richardson histologic grading scheme for infiltrating ductal
carcinoma. Am J Clin Pathol. 103:195–198. 1995.PubMed/NCBI
|
|
17
|
Mylona E, Giannopoulou I, Fasomytakis E,
Nomikos A, Magkou C, Bakarakos P and Nakopoulou L: The
clinicopathologic and prognostic significance of CD44+/CD24(−/low)
and CD44-/CD24+ tumor cells in invasive breast carcinomas. Human
Pathol. 39:1096–1102. 2008. View Article : Google Scholar
|
|
18
|
Jasani B and Rhodes A: The role and
mechanism of high-temperature antigen retrieval in diagnostic
pathology. Curr Diag Pathol. 7:153–160. 2001. View Article : Google Scholar
|
|
19
|
Currie MJ, Beardsley BE, Harris GC,
Gunningham SP, Dachs GU, Dijkstra B, Morrin HR, Wells JE and
Robinson BA: Immunohistochemical analysis of cancer stem cell
markers in invasive breast carcinoma and associated ductal
carcinoma in situ: Relationships with markers of tumor hypoxia and
microvascularity. Human Pathol. 44:402–411. 2013. View Article : Google Scholar
|
|
20
|
Shimizu M, Saitoh Y and Itoh H:
Immunohistochemical staining of Ha-ras oncogene product in normal,
benign, and malignant human pancreatic tissues. Hum Pathol.
21:607–612. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moeller BJ, Cao Y, Li CY and Dewhirst MW:
Radiation activates HIF-1 to regulate vascular radiosensitivity in
tumors: Role of reoxygenation, free radicals, and stress granules.
Cancer cell. 5:429–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Horbinski C, Mojesky C and Kyprianou N:
Live free or die: Tales of homeless (cells) in cancer. Am J Pathol.
177:1044–1052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Duffy JP, Eibl G, Reber HA and Hines OJ:
Influence of hypoxia and neoangiogenesis on the growth of
pancreatic cancer. Mol Cancer. 2:122003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei B, Han XY, Qi CL, Zhang S, Zheng ZH,
Huang Y, Chen TF and Wei HB: Coaction of spheroid-derived stem-like
cells and endothelial progenitor cells promotes development of
colon cancer. PloS One. 7:e390692012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martin TA and Jiang WG: Evaluation of the
expression of stem cell markers in human breast cancer reveals a
correlation with clinical progression and metastatic disease in
ductal carcinoma. Oncol Rep. 31:262–272. 2014.PubMed/NCBI
|
|
26
|
Platet N, Liu SY, Atifi ME, Oliver L,
Vallette FM, Berger F and Wion D: Influence of oxygen tension on
CD133 phenotype in human glioma cell cultures. Cancer Lett.
258:286–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bao S, Wu Q, Sathornsumetee S, Hao Y, Li
Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD and Rich JN: Stem
cell-like glioma cells promote tumor angiogenesis through vascular
endothelial growth factor. Cancer Res. 66:7843–7848. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Panchision DM: The role of oxygen in
regulating neural stem cells in development and disease. J Cell
Physiol. 220:562–568. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Soeda A, Park M, Lee D, Mintz A,
Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T,
Kassam AB, et al: Hypoxia promotes expansion of the CD133-positive
glioma stem cells through activation of HIF-1α. Oncogene.
28:3949–3959. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC,
Jiang T, Lin MC, Chen JH, Wang B, Zhang R, et al: The chemokine
CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated
VEGF production and tumour angiogenesis via PI3K/AKT signalling. J
Pathol. 224:344–354. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Silva IA, Bai S, McLean K, Yang K,
Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds
RK, et al: Aldehyde dehydrogenase in combination with CD133 defines
angiogenic ovarian cancer stem cells that portend poor patient
survival. Cancer Res. 71:3991–4001. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fanelli M, Locopo N, Gattuso D and
Gasparini G: Assessment of tumor vascularization:
Immunohistochemical and non-invasive methods. Int J Biol Markers.
14:218–231. 1999.PubMed/NCBI
|
|
33
|
Pufe T, Harde V, Petersen W, Goldring MB,
Tillmann B and Mentlein R: Vascular endothelial growth factor
(VEGF) induces matrix metalloproteinase expression in immortalized
chondrocytes. J Pathol. 202:367–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takase Y, Kai K, Masuda M, Akashi M and
Tokunaga O: Endoglin (CD105) expression and angiogenesis status in
small cell lung cancer. Pathol Res Pract. 206:725–730. 2010.
View Article : Google Scholar : PubMed/NCBI
|
